Gallagher Duncan
Director at HCAT
- Sold, on record
- $63k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Dec 30, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- HCATHealth Catalyst, Inc.Director
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice HCATNoticeDec 23, 2024 2024
Filed to sell 4,500 shares ($32k)
Gallagher Duncan, Director
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale HCATRoutineDec 23, 2024 same day
Sold 4,500 shares at $6.98 ($31k)
Gallagher Duncan, Director
10b5-1 planSold 5.7% of holdings ($551k position)74,438 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice HCATNoticeDec 30, 2024 +7 days
Filed to sell 4,500 shares ($32k)
Gallagher Duncan, Director
10b5-1 planFiling
- 4 Form 4 sale HCATRoutineDec 30, 2024 same day
Sold 4,500 shares at $6.93 ($31k)
Gallagher Duncan, Director
10b5-1 planSold 6% of holdings ($516k position)69,938 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | Jan 2, 2025 | HCAT | Director | Form 4 sale | 4,500 | $31k | 6.0% | Routine | SEC |
| Dec 30, 2024 | Dec 30, 2024 | HCAT | Director | Form 144 notice | 4,500 | $32k | Notice | SEC | |
| Dec 23, 2024 | Dec 27, 2024 | HCAT | Director | Form 4 sale | 4,500 | $31k | 5.7% | Routine | SEC |
| Dec 23, 2024 | Dec 23, 2024 | HCAT | Director | Form 144 notice | 4,500 | $32k | Notice | SEC |